Helena Colom

A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach

Franc Andreu, Helena Colom, Laure Elens et al. · Clinical Pharmacokinetics · 2017 · 92 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets

J. Saurí, Diana Millán, Josep M. Suñé‐Negre et al. · International Journal of Pharmaceutics · 2014 · 80 citations

Pharmacy, Pharmaceutics, Pharmacology +17

The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation

Núria Lloberas, Laure Elens, Inés Llaudó et al. · Pharmacogenetics and Genomics · 2017 · 71 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

A Comparative In Vitro Study of Transdermal Absorption of a Series of Calcium Channel Antagonists

I. Díez, Helena Colom, J.M. Moreno et al. · Journal of Pharmaceutical Sciences · 1991 · 68 citations

Pharmacy, Pharmaceutics, Pharmacology +15

Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus

Helena Colom, Y. Armendáriz, Marı́a J. Garrido et al. · Antimicrobial Agents and Chemotherapy · 2009 · 58 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17